ARK Genomic Revolution ETF (ARKG) |
| 29.98 -0.58 (-1.9%) 02-27 16:00 |
| Open: | 29.895 |
| High: | 30.26 |
| Low: | 29.55 |
| Volume: | 2,089,258 |
| Market Cap: | 1,209(M) |
| PE Ratio: | 0 |
| Exchange: | Chicago Board Options Exchange |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 34.19 |
| Resistance 1: | 31.58 |
| Pivot price: | 29.14 |
| Support 1: | 27.36 |
| Support 2: | 22.76 |
| 52w High: | 34.39 |
| 52w Low: | 17.505 |
The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Fri, 20 Feb 2026
Friday's ETF Movers: GTOP, ARKG - Nasdaq
Tue, 17 Feb 2026
(ARKG) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Mon, 16 Feb 2026
IHI, IHE, ARKG: Specialty Healthcare ETFs Can Help Boost a Portfolio - TipRanks
Wed, 11 Feb 2026
7 Best Biotech ETFs to Buy Now - US News Money
Tue, 06 Jan 2026
Cathie Wood Loads Up On Tempus AI And This George Soros-Backed Company's Stock, Dumps Roku And Shopify Shares - Sahm
Mon, 05 Jan 2026
Cathie Wood’s ARK Invest Shifts 2026 Strategy, Heavily Bets on Gene Editing Technology - NAI500
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
